Skip to main content

Table 3 Logistic regression analysis of risk factors for metastatic sites

From: miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer

Variables

Lung

Brain

Liver

Bone

Othersa

OR

95% CI

P value

OR

95% CI

P value

OR

95% CI

P value

OR

95% CI

P value

OR

95% CI

P value

Age

Menopause

T3/4

1.1

0.7–1.5

0.748

1.4

0.8–2.2

0.167

1.5

0.9–2.3

0.080

0.9

0.6–1.2

0.435

1.7

1.0–3.0

0.049

N1/2/3

1.5

1.0–2.2

0.046

0.8

0.5–1.3

0.348

1.9

1.1–3.1

0.014

1.2

0.8–1.8

0.330

1.3

0.7–2.3

0.405

TNM II/III

1.7

0.8–3.4

0.143

2.0

0.8–5.2

0.138

1.0

0.4–2.6

0.994

3.0

1.4–6.5

0.005

1.4

0.4–4.7

.597

Surgery

Chemotherapy

Grade II/III

1.3

0.9–1.9

0.105

1.7

1.0–2.8

0.039

1.6

1.1–2.3

0.026

1.9

1.0–3.9

0.044

Ki-67

LVI (positive)

0.9

0.5–1.7

0.863

4.1

1.9–8.4

<0.001

1.1

0.5–2.4

0.760

1.3

0.7–2.4

0.371

miR-629-3p (high)

4.1

2.5–6.6

<0.001

1.6

0.8–3.1

0.147

  1. LVI Lymphovascular invasion
  2. A blank (–) field indicates that the variable was not significant in the univariate analysis and was not included in the multivariate analysis
  3. a“Others” refers to distant nodal, pleural/peritoneal, abdominal/mediastinal viscera, spinal cord, eye, and other unclassified organs